Robert Joseph Stratta, MD
Robert Joseph Stratta, MD, Professor of Surgery, Department of General Surgery, Associate Professor, Institute for Regenerative Medicine
Dr. Stratta is Professor of Surgery and Director of Transplantation at Wake Forest Baptist Health, which is currently one of the largest kidney and pancreas transplant centers in the US. He accepted this appointment in October 2001 following many years as Professor of Surgery and Director of Pancreas Transplantation at the University of Nebraska Medical Center and Clarkson Hospital, and as Professor of Surgery at the University of Tennessee, Memphis. After earning his B.S. degree at the University of Notre Dame, Dr. Stratta received his M.D. degree from the University of Chicago-Pritzker School of Medicine and trained in General Surgery at the University of Utah. He then completed a transplant clinical and research fellowship at the University of Wisconsin-Madison. He is co-author of 5 books, over 37 book chapters, 685 abstracts, 413 manuscripts, 102 internet and 406 oral presentations dealing predominantly with transplantation. He has accumulated more than $9 million in career research funding. He has been active in medical school, surgical resident, and transplant fellow education since 1988; is a member of 25 medical societies; three editorial and physician review boards each; and numerous local, regional, and national committees including United Network for Organ Sharing (UNOS) activities since 1988. He is Past President of the Executive Board of Directors of Carolina Donor Services and is currently Councillor of UNOS Region 11 and a member of the UNOS Board of Directors. He has lectured worldwide on kidney and pancreas transplantation, has performed more than 2000 transplants in his career, is board certified in General Surgery and Surgical Critical Care, and has been selected as one of the Best Doctors in America since 1993, one of America's Top Surgeons since 2004, and is currently listed as one of America’s Top Doctors and the Patients’ Choice Award.
SYNOPSIS OF AREA OF INTEREST: Main areas of research interest include all clinical aspects of kidney and pancreas transplantation, transplant options for the diabetic patient, new immunosuppressive drug regimens, prophylaxis and treatment of opportunistic infections, organ donation and allocation, quality of life studies in transplantation, and economic aspects of transplantation. In addition, new areas of interest include the use of expanded criteria donors, organ preservation and delayed graft function, the impact of the metabolic syndrome pre and post-transplant, and transplantation of high-risk patients (elderly, African American, highly sensitized, or retransplant candidates).
DETAILED AREA OF INTEREST: Dr. Statta's areas of research interest include kidney and pancreas transplantation, immunosuppressive strategies, opportunistic infections, organ donation and allocation, quality of life, and economic aspects of transplantation. As short-term results have consistently improved in transplantation, a paradigm shift has occurred and clinical transplantation research is now focused on long-term outcomes such as organ durability and function, composite endpoints, quality of life, economic aspects, chronic effects of immunosuppression (cardiovascular, malignancy, infectious, metabolic aspects), decreasing chronic allograft failure (both immunological and non-immunological causes), and strategies of prevention. The long-term effects of pancreas (or islet) transplantation on the secondary complications of diabetes remain a pivotal area of interest and research. In general, the emphasis has shifted away from short-term immunological and surgical outcomes to long-term quality aspects coupled with expanded donor and recipient selection criteria. The critical shortage of donor organs remains an overwhelming crisis in organ transplantation. Consequently, optimizing the current supply and actively investigating new sources or organs through regenerative medicine techniques represents a key feature of our academic and clinical pursuits.